InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by FitzPatrick Margaret M. Director active across 1 company, notably AN2 Therapeutics, Inc.. In total, 1 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 28 May 2025. The latest transaction was disclosed on 28 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration